+34 679 490 537info@nanbiosis.com

Nanbiosis Committees

Nanbiosis

Coordination Committee

  • Jaume Veciana, Scientific Director of NANBIOSIS; Director of  Molecular Nanosciences and Organic Materials Dpt. (ICMAB-CSIC)  and Coordinator of Platform Programme of CIBER BBN.
  • Francisco Miguel Sánchez Margallo; Assistant Director of NANBIOSIS and Scientific Director of JUMISC
  • Ramón Martínez Máñez, Scientific Director of CIBER-BBNPI of  the Group of Applied Molecular Chemistry Center of Molecular Recognition and Technological Development of the Polytechnic University of Valencia (UPV-ADM-IQMA) Scientific Director of NANBIOSIS Unit 26
  • María Luisa García Martín, Scientific Director of NANBIOSIS Unit 28, PI of the Group Biomedical Magnetic Resonance Laboratory-BIONAND,
  • Pablo Laguna, Scientific Director of NANBIOSIS Unit 27, PI of the Biomedical Signal Interpretation and Computational Simulation (BSICoS) group; Scientific Coordinator of  I3A (Aragon Institute of Engineering Research)
  • Verónica Crisóstomo, Researcher at the Endoluminal Diagnostic and Therapeutic Unit of the Minimally Invasive Surgery Center Jesús Usón.
  • Nerea Argárate; Coordinator of NANBIOSIS. Responsible for Infrastructures and Research Services of CIBER BBN.
  • Raquel Ruiz Hidalgo; Deputy Coordinator of NANBIOSIS; R&D&i Coordinator of JUMISC.

Scientific-Technical Advisory Board

  • Ignacio Santiago Álvarez, Professor of the University of Extremadura / Scientific Director IERA-GC, Badajoz
  • Joaquin Arribas, Director of Preclinical Research VHIO and Head of the Growth Factors Laboratory, Barcelona
  • Francisco Fernández Avilés, Chair of the Department of Cardiology, University Hospital Gregorio Marañón, Madrid
  • Antonio Bernad, Research Proffessor at Immunology and Onocology Department, National Center for Biotechnology (CNB), Madrid
  • Jürguen Borlak, Director of Institute for Pharmaco- and Toxicogenomics, Hannover Medical School, Germany
  • Pilar Calvo, Pharmaceutical Development Manager of PHARMAMAR
  • Begoña Castro, Scientific Director of Histocell, Madrid
  • Stefania Raimondo, Professor of the University of Turin, Italy
  • Manuel Sarasa, Professor of Comparative Anatomy and Pathological Anatomy at the University of Zaragoza, Scientific Director of Araclon Biotech S.L., Zaragoza
  • Ruth Schmid. Vicepresident SINTEF, Norway
  • Anton Ussi, Operations and Finance director at EATRIS ERIC, the European Infrastructure for Translational Medicine, Amsterdam, The Netherlands

Access Committee

  • Jaume Veciana, Scientific Director of NANBIOSIS; Director of  Molecular Nanosciences and Organic Materials Dpt. (ICMAB-CSIC)
  • Francisco Miguel Sánchez Margallo; Assistant Director of NANBIOSIS and Scientific Director of JUMISC
  • Niilo Saranummi (VTT Technical Research Centre of Finland).
  • Miguel Angel de Gregorio (Prof. of Interventional Radiology, University of Zaragoza)
  • Virginio García Martínez (University of Extremadura, Spain)
  • Hector Ferral (Department of Radiology, Section of Interventional Radiology, NorthShore University HealthSystem)
  • Mª Eugenia Fernández Santos, (Director of Cellular Production Unit and Regenerative Medicine, Director of GMP facilities of Hospital Gregorio Marañón)